| SOLID-DOSAGE DRUGS |

Choosing Capsules: A Primer

Capsules offer certain benefits over tablets for oral-solid dosage drugs, and several types of capsules are available.
/ read more /

Is Your Tablet Hard to Swallow? Guidance Addresses Drug Tablet Design

EMA and FDA guidance encourages design of drug products to improve patient compliance.
/ read more /

| SINGLE-USE BIOREACTORS |

Testing and Simulation Approaches for Single-Use Bioreactor Scale-up

Tools aid scale-up and comparison of single-use and stainless-steel bioreactors.
/ read more /

| EXCIPIENTS|

The Real Complexity of Excipient Composition

This article seeks to promote dialogue among stakeholders to facilitate consensus regarding requirements for excipients.
/ read more /

| SUPPLY CHAIN|

Real-Time Logistics

Internet of things, advanced analytics, and blockchain solutions such as smart contracts promise to give manufacturers more control over products and supply chains.
/ read more /

| ANALYTICS |

Automated Visual Particle Inspection

This article discusses fully automatic inspection of glass and plastic containers and factors that affect particle detection rate.
/ read more /

| PEER-REVIEWED RESEARCH |

How to Monitor HPMC Concentration Through Conductivity Measurement

The authors demonstrate that a proper measure of HPMC solution concentration is its electrical conductivity rather than its viscosity.
/ read more /

| EU REGULATORY WATCH |

Pharmaceutical Environmental Pollution and Antimicrobial Resistance

The European Commission is striving to tackle environmental pollution by pharmaceuticals as a means of curbing antimicrobial resistance.
/ read more /

| OUTSOURCING OUTLOOK |

Up and Away, M&A

Mergers and acquisitions are positive for the CDMO industry, but there is a downside.
/ read more /

| API SYNTHESIS AND MANUFACTURING |

Managing Potentially Potent APIs

CDMOs have established strategies for handling new chemical entities with unknown biological activity.
/ read more /

| ASK THE EXPERT |

Making Decisions Based on Risk

Focusing on whether the product meets its defined quality attributes should help one make reasonable, documentable, and defendable risk-based decisions, according to Susan Schniepp, distinguished fellow at Regulatory Compliance Associates.
/ read more /